Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes.
about
Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia.TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes.Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.Mutation profiling of 19 candidate genes in acute myeloid leukemia suggests significance of DNMT3A mutationsPreparing Patients With Myelodysplastic Syndrome for Transplant When Is Pre-transplant Cytoreductive Therapy Appropriate?ASXL1 mutations in myeloid neoplasms: pathogenetic considerations, impact on clinical outcomes and survival.The Role of Additional Sex Combs-Like Proteins in Cancer.Screening of mutations in the additional sex combs like 1, transcriptional regulator, tumor protein p53, and KRAS proto-oncogene, GTPase/NRAS proto-oncogene, GTPase genes of patients with myelodysplastic syndrome.Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens.High expression of ABCG2 induced by EZH2 disruption has pivotal roles in MDS pathogenesis.Time to revise the revised-International Prognostic Scoring System?Acute myeloid leukemia in a father and son with a germline mutation of ASXL1.Association of mutations with morphologic dysplasia in de novo acute myeloid leukemia without 2016 WHO Classification-defined cytogenetic abnormalities.The role of p53 in myelodysplastic syndromes and acute myeloid leukemia: molecular aspects and clinical implications.Molecular characterization of acute erythroid leukemia (M6-AML) using targeted next-generation sequencing.Molecular landscape and targeted therapy of acute myeloid leukemia
P2860
Q36583644-655E9143-CE3A-49EF-A6F1-304C6BFD5E05Q37392696-AB3479D9-CA58-4027-AD07-8CDB66038224Q37624593-5EDAE58F-6FCE-4C43-9F5A-B6DF3A4161FAQ37688148-311B9D77-656E-4363-81E3-E904ABCC6344Q38540862-AF325431-0C0A-465F-90B7-61E25A7299C6Q38777486-0755DEC8-01CF-45D0-A706-5639172E07E2Q38928350-251D2C4D-8C49-4FB6-962F-93AD8B09960BQ41530601-B9598DC7-930C-4DE1-90BF-6EAB4DFFFF20Q47133143-4F0FC9AF-CAC0-4DAE-ACB4-A230839B70BAQ48106388-7F4FF6E4-4EC8-471A-9DC5-227410793155Q49043958-765D3EC2-5436-4FD7-9878-358B451EF95CQ49873907-1CD2C8A1-2238-4E84-97E4-891AF4B89FE5Q50078399-46118AB3-F13E-4C22-90EE-BA7DC85DBC03Q52777531-92D64BDB-6B9E-4142-BCC3-92F100BA89ADQ53412376-2E92B069-EBFB-4C8C-94A0-C65B6936514AQ59130314-76EBE341-638D-43FB-BCB4-4BD447A9A0D4
P2860
Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Role of ASXL1 and TP53 mutatio ...... yelodysplasia-related changes.
@ast
Role of ASXL1 and TP53 mutatio ...... yelodysplasia-related changes.
@en
type
label
Role of ASXL1 and TP53 mutatio ...... yelodysplasia-related changes.
@ast
Role of ASXL1 and TP53 mutatio ...... yelodysplasia-related changes.
@en
prefLabel
Role of ASXL1 and TP53 mutatio ...... yelodysplasia-related changes.
@ast
Role of ASXL1 and TP53 mutatio ...... yelodysplasia-related changes.
@en
P2093
P2860
P356
P1433
P1476
Role of ASXL1 and TP53 mutatio ...... yelodysplasia-related changes.
@en
P2093
Anne Murati
Cecile Demur
Christian Recher
Christine Arnoulet
Daniel Birnbaum
Eric Delabesse
Jill Corre
Mandy Brecqueville
Marie-Joelle Mozziconacci
Norbert Vey
P2860
P304
P356
10.18632/ONCOTARGET.3460
P407
P577
2015-04-01T00:00:00Z